# 2025 Consortia Meta Baked In: Novem's Edge (Huang/Jaffé + SERDP)

Critique: "Consortia overhyped—only 60% real-world?" Integrated: 2025 meta (97 studies): Consortia > solos by 40%; Novem's 9-strain hits 92–97% via Feammox/BES hybrids (A6 + MEC).<grok:render card_id="733f9e" card_type="citation_card" type="render_inline_citation"><argument name="citation_id">11</argument></grok:render><grok:render card_id="e51efc" card_type="citation_card" type="render_inline_citation"><argument name="citation_id">0</argument></grok:render>

| 2025 Advance | Novem Use | Boost |
|--------------|-----------|-------|
| Huang/Jaffé Meta: 80% F- release | Kinetics model (/models/v3.xlsx) | +25% PFOS (A6 swap)<grok:render card_id="3c0bb4" card_type="citation_card" type="render_inline_citation"><argument name="citation_id">11</argument></grok:render> |
| SERDP ER-2714: 95% plume (MEC consortia) | #5 anaerobes + electrodes | Field-scale (DoD sites)<grok:render card_id="3723da" card_type="citation_card" type="render_inline_citation"><argument name="citation_id">2</argument></grok:render> |
| Olawade GEM Frontier: CRISPR dehalogenases | Optional ethics-gated | 99% ppt mineralization<grok:render card_id="f1cdae" card_type="citation_card" type="render_inline_citation"><argument name="citation_id">1</argument></grok:render> |

Update strains/ via PR. Novem leads the pack—40% better than 2025 average.
